sch 58261 has been researched along with fk 453 in 1 studies
| Studies (sch 58261) | Trials (sch 58261) | Recent Studies (post-2010) (sch 58261) | Studies (fk 453) | Trials (fk 453) | Recent Studies (post-2010) (fk 453) |
|---|---|---|---|---|---|
| 46 | 0 | 14 | 20 | 2 | 0 |
| Protein | Taxonomy | sch 58261 (IC50) | fk 453 (IC50) |
|---|---|---|---|
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0171 | |
| Adenosine receptor A2b | Homo sapiens (human) | 0.98 | |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 8.1 | |
| Adenosine receptor A2a | Cavia porcellus (domestic guinea pig) | 1.18 | |
| Adenosine receptor A1 | Cavia porcellus (domestic guinea pig) | 0.0006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, ZG; Jacobson, KA | 1 |
1 review(s) available for sch 58261 and fk 453
| Article | Year |
|---|---|
Adenosine receptors as therapeutic targets.
Topics: Animals; Disease; Drug Therapy; Humans; Ligands; Molecular Structure; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction; Structure-Activity Relationship | 2006 |